Long-Term Treatment of Collagenous Colitis With Budesonide
Status:
Unknown status
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis.
All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks
treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms
(number of daily stools)